# Assess the Efficacy of Whole Brain Radiation Therapy in Lung Cancer Patients With Brain Metastasis

> **NCT01363557** · NA · TERMINATED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 1 (actual)

## Conditions studied

- EGFR-mutated Lung Adenocarcinoma
- Brain Metastasis

## Interventions

- **OTHER:** whole brain radiotherapy
- **DRUG:** Gefitinib (IRESSA)

## Key facts

- **NCT ID:** NCT01363557
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-03
- **Primary completion:** 2012-08
- **Final completion:** 2013-05
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Decision of Sponsor
- **Last updated:** 2014-05-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01363557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01363557, "Assess the Efficacy of Whole Brain Radiation Therapy in Lung Cancer Patients With Brain Metastasis". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT01363557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*